Michael Harrington to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Michael Harrington has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.185
-
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial. J Immunother Cancer. 2026 Jan 14; 14(1).
Score: 0.185
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.